Randomized, Double-Blind, Phase III Trial of Olaparib vs. Placebo in Patients with Advanced FIGO Stage IIIB – IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer treated with standard First-Line Treatment, Combining Platinum-Taxane Chemotherapy and Bevacizumab Concurrent with Chemotherapy and in Maintenance.
Study sites
- CHR Citadelle, Liège
- Clinique et maternité St. Elizabeth, Namur
- Cliniques universitaires de Mont-Godinne, Yvoir
- Institut Jules Bordet, Bruxelles
- UZ Antwerpen, Edegem
- UZ Leuven, Leuven
